Campylobacter jejuni is responsible for tens of millions of cases of gastroenteritis each year. Despite its prevalence and impact on human health, the repertoire of genetic tools available for researchers to study C. jejuni remains limited. In order to expand upon the genetic toolkit in this species, we have engineered a system for generating conditional knockouts based on the tetRA tetracycline-resistance cassette. This system exhibits tight repressibility and titratability of target-gene expression and will be useful for future research on this important human pathogen.
By replacing the native tetRA promoters with synthetic, C. jejuni-derived promoter regions, we were able to construct a functional tetRA-based expression system for use in C. jejuni. The tetRA-derived cassettes possess tight repressibility as well as titratability of target-gene expression. To the best of our knowledge, this is the first inducible-promoter system developed for use in this species.
Results:
Design of tetRA C.j. :
Using DRH212 (14) , a tetracycline-sensitive strain of C. jejuni 81-176, as our wild-type (WT) strain, we tested several tetRAs harboring engineered promoters for their ability to confer tetracycline resistance when integrated in the chromosome. The synthetic promoters were generated by replacing the entire Tn10 tetRA promoter region with C. jejuni promoters harboring tetO2 sequences. Of those tested, only one was found to enable growth on media containing tetracycline.
The functional C. jejuni tetRA, tetRA C.j. v1 , was generated by placing tetR downstream of the rpsL promoter and tetA under the control of a modified rpsO promoter harboring a single tetO2 sequence between its -10 region and ribosome binding site (RBS) (Fig. 1B) . rpsL and rpsO code for protein subunits of the ribosome and are highly expressed in C. jejuni. The rpsL promoter driving tetR transcription does not contain a tetO2 sequence and is therefore constitutively expressed.
Optimization of tetRA C.j.
In order to test the properties of tetRA C.j. v1 , we placed the cassette just upstream of astA, encoding arylsulfatase, generating the PastA::tetRA C.j. v1 reporter strain. Arylsulfatase catalyzes the release of inorganic sulfate from arylsulfate esters and has previously been used as a reporter for gene expression in C. jejuni (15, 16) .
tetRA C.j. v1 was found to downregulate astA expression in the absence of inducer (Anhydrotetracycline (ATc)), and overexpress astA in its presence, relative to WT expression levels ( Fig. 2A ). However, repression of astA by tetRA C.j. v1 was incomplete, which was evident by cultivating this mutant on media containing a chromogenic arylsulfatase substrate (5-bromo-4-chloro-3-indolylsulfate (XS)) lacking ATc.
In an attempt to more fully repress astA expression in the absence of ATc, two derivatives of tetRA C.j. v1 were constructed: tetRA C.j. v2 and tetRA C.j. v3 . Each derivative harbors two tetO2 sequences in the rpsO promoter, in different locations ( Fig. 1B) . Insertion of a second tetO2 site resulted in tighter repression in both PastA::tetRA C.j. v2 and PastA::tetRA C.j. v3 relative to PastA::tetRA C.j. v1 on XS agar without ATc. PastA::tetRA C.j. v2 demonstrated somewhat higher astA expression than PastA::tetRA C.j. v3 on XS agar with ATc added. However, both derivatives still exhibited identical, low-level astA expression phenotypes in the absence of ATc ( Fig. 2A ).
The observation that PastA::tetRA C.j. v2 and PastA::tetRA C.j. v3 exhibited different phenotypes on XS agar containing ATc, but the same appearance on XS agar lacking ATc suggested that an undesirable level of gene expression in the uninduced state was intrinsic to the tetRA C.j. cassettes. We presumed that this was due to either incomplete repression of the synthetic rpsO promoters by TetR or the presence of cryptic promoter elements within the tetA coding region that were being recognized by C. jejuni RNAP.
To determine if the leakiness of tetRA C.j. cassettes could be attributed to background readthrough from within the tetA sequence, tetA was deleted from all three tetRA C.j. variants. We found that by deleting tetA, we were able to reduce astA expression below detectable levels on X-S agar in both the PastA::tetRA C.j. v2 and PastA::tetRA C.j. v3 backgrounds (Fig. S2 ).
However, excision of tetA sacrificed an advantageous feature of the tetRA C.j. cassettes: the ability to generate conditional-knockout mutants in the chromosome in one step by selecting for tetracycline resistance. This was addressed by generating a transcriptional fusion of the gene encoding chloramphenicol acetyltransferase, cat, to tetR. Thus, insertion of the derived cassettes, cat-tetR_PtetA v1-3 , can be selected for on media containing chloramphenicol. Comparison of astA expression in PastA::tetR_PtetA v2 and PastA::cat-tetR_PtetA v2 genetic backgrounds showed that addition of the cat gene did not disrupt the function of the cassettes ( Fig 2B) .
We next constructed a conditional knockout of flgR in order to confirm the results obtained at the astA locus. The FlgR protein is a response regulator that links completion of the C. jejuni flagellar type three secretion system (fT3SS) to the subsequent expression of genes required for assembly of the flagellar hook basal body (16) . Mutants lacking a functional copy of flgR are non-motile due to their inability to construct a flagellum.
cat-tetR_PtetA v2 and cat-tetR_PtetA v3 were inserted in the chromosome directly upstream of the flgR start codon and tested for their ability repress motility in the absence of ATc. Motility agar with and without ATc added were inoculated with the conditionalknockout mutants and allowed to incubate for 12 hours. We found that both cat-tetR_PtetA v2 and cat-tetR_PtetA v3 repressed motility in media lacking ATc, and produced motility swarms of approximately WT diameter in the presence of ATc.
In addition to the cat-tetR_PtetA v2 and cat-tetR_PtetA v3 derivatives of tetRA C.j. v1 , we also constructed a cassette with the tetR V99E mutation with the v3 promoter, cat-RevtetR_PtetA v3 . The V99E mutation converts TetR to a co-repressor in the presence of ATc, i.e. TetR V99E binds to tetO sequences in the presence of ATc and represses downstream gene expression. When inserted upstream of flgR, the cat-RevtetR_PtetA v3 repressed motility in the presence of ATc ( Fig. 2C )
Gene expression from cat-tetR_PtetA is titratable:
An attractive feature of tetRA-derived promoter systems is the ability to upregulate and downregulate expression of the target gene. To determine if gene expression was titratable using the cat-tetR_PtetA cassettes, we incubated the PastA::cat-tetR_PtetA v2 mutant on media containing ATc in concentrations ranging from 0 to 0.4 g/mL.
Following overnight incubation on varying concentrations of ATc, AstA activity was measured as a proxy for astA expression. We found that AstA activity ranged from undetectable levels when incubated without ATc to a peak of ~70 arylsulfatase units/hr. at a concentration of 0.3-0.4 g/mL, similar to the WT expression level in DRH212 ( Fig.  3B ). Cultures grown on media containing lower concentrations of ATc exhibited correspondingly lower AstA activity, indicating that expression of genes under control of the cat-tetR_PtetA cassettes is titratable. Similar results were obtained by western blot probing for FlgR protein in the PflgR::cat-tetR_PtetA v2 and PflgR::cat-tetR_PtetA v3 backgrounds grown on varying concentrations of ATc (Fig. 3A) .
To confirm the results obtained with astA, we decided to test the functionality of the cassette on another gene, pgp1. C. jejuni owes its helical cell shape to the action of a handful of enzymes, including Pgp1, that determine peptidoglycan architecture (17) . Loss of Pgp1 activity results in a straight, non-helical body morphology.
We generated a markerless deletion of pgp1 that leaves the first and last 52 codons of the gene intact in order to reduce the likelihood of polarity on neighboring genes. As expected, the pgp1 mutant exhibited a straight-body morphology but otherwise appeared normal (i.e. WT growth rate, flagella number and cell size). Into this background we inserted a copy of pgp1 under the control of the cat-tetR_PtetA v2 cassette at the astA locus, resulting in the pgp1 PastA::cat-tetR_PtetA v2 astA::pgp1 mutant.
The pgp1 conditional knockout strain was incubated overnight on media containing a range of ATc concentrations, from 0 to 0.3 g/mL, and subsequently observed by transmission electron microscopy. Cells grown in the absence of ATc exhibited a pgp1 straight-body phenotype, while those incubated on ATc displayed helical body morphologies ( Fig. 3C) . At the lowest level of ATc tested (0.1 g/mL), we observed cell shape phenotypes that were neither WT nor that of a pgp1 knockout, but intermediate between the two. Cells grown on 0.3 g/mL ATc had a WT cell shape.
The cat-tetR_PtetA cassette is functional in multiple strains of C. jejuni C. jejuni 81-176, a highly invasive clinical isolate, is one of several strains commonly used for research purposes. To test whether the cat-tetR_PtetA cassettes are functional in other strains of C. jejuni, we constructed a plasmid, pEJC1, harboring the cat-tetR_PtetA v2 cassette driving GFP expression. pEJC1 was conjugated into two strains of C. jejuni, PT14 and 11168H, and tested for GFP expression in the presence and absence of ATc. When incubated on media lacking ATc, we did not observe fluorescence in either background ( Fig. 4 ). In the presence of ATc, both strains fluoresced, suggesting that the cat-tetR_PtetA cassettes can be used in all strains of C. jejuni.
Discussion:
A multifaceted genetic toolkit is required in order to dissect the molecular mechanisms that underpin the behavior and physiology of any organism. Through the efforts of researchers over several decades, a number of genetic tools have been developed that allow for the genetic manipulation of C. jejuni. In the work presented here, we have added to that toolkit the ability to generate conditional knockouts and to titrate gene expression in this important human pathogen.
The tetRA system was chosen for several reasons. First, tetRA gene-expression systems exhibit tight repressibility in the absence of inducer as well as titratability of target-gene expression. Furthermore, the inducers used (e.g. ATc) are membrane permeable, obviating the need for importers of the inducing molecule (e.g. LacY for IPTG). Not only does this reduce the size and complexity of tetRA systems, but also allows for target-gene induction across multiple cell membranes, a useful feature when studying intracellular pathogens (such as C. jejuni) (9, 11) .
Although the strain of C. jejuni we used for this work, DRH212, is sensitive to tetracycline, many strains of C. jejuni display tetracycline resistance. Resistance in these strains is conferred by the tetO gene (different from the tetO operator sequences found in the tetRA promoter region) either carried on a plasmid or encoded in the genome (18) . The TetO protein confers resistance by preventing tetracycline from binding to the ribosome, as opposed to TetA, which is a tetracycline-efflux pump. An advantage of the tetRA C.j. -derivative cassettes, cat-tetR_PtetA v1-3 , is the ability to generate conditional knockout mutants in both tetracycline-sensitive and resistant strains of C. jejuni in one step by selecting for chloramphenicol resistance.
The tetRA C.j. v1 -derivatives, cat-tetR_PtetA v2 and cat-tetR_PtetA v3 , display tight repressibility, titratability and gene-expression profiles over physiologically relevant ranges for the genes studied here, and are currently being used for several projects in our lab. However, we anticipate that it would be relatively straightforward for other researchers to construct tetRA C.j. -based systems with customized expression profiles depending on their needs. We tested only three native C. jejuni promoters in our initial attempt to generate a functional tetRA C.j. cassette, suggesting that this approach would work with many other promoter sequences.
Materials and Methods:
Bacterial strains and growth conditions:
Strains of C. jejuni were routinely grown microaerobically (5% O2, 10% CO2, 85% N2) at 37 C on Mueller-Hinton (MH) agar supplemented with 10 g/mL of trimethoprim. When necessary, media was supplemented with additional antibiotics at the following concentrations: kanamycin: 50 g/mL, chloramphenicol: 7.5 g/mL, streptomycin: 2 mg/mL, tetracycline: 5-10 g/mL (concentration varied by mutant), anhydrotetracycline (0.05-0.4 g/mL)
Genetic manipulation of C. jejuni
Chromosomal mutations in C. jejuni were constructed by transforming linear pieces of DNA generated by splicing-by-overhang-extension PCR (SOE PCR). Individual fragments were designed that possessed 5' and/or 3' sequence homology to one another using Q5 high-fidelity DNA polymerase (New England Biolabs), followed by stitching the individual fragments together in a SOE reaction.
Following synthesis of DNA, fragments were transformed into C. jejuni using the biphasic method. Briefly, a 5 mm plate with 5 mL MH agar was overlaid with 5-10 g DNA. Then, C. jejuni grown overnight on MH agar was suspended to an O.D.600 of ~0.5 in MH broth. 1 mL of cell suspension was added to the DNA-seeded plate and allowed to incubate microaerobically at 37 C for 6-8 hours before being transferred to appropriate selective media and allowed to incubate 3-5 days.
For construction of the markerless pgp1 strain, an aph3'-rpsL (kan-rpsL) cassette was first inserted into pgp1 in DRH212. Insertion of kan-rpsL into pgp1 was selected for via kanamycin resistance. Next, a linear fragment generated by SOE encoding a clean deletion of ~350 codons of pgp1 flanked by ~500 bp of upstream and downstream homology to the desired deletion was transformed into the pgp1:: kan-rpsL intermediate strain, followed by incubation on MH agar supplemented with 2 mg/mL streptomycin for four days. Streptomycin-resistant colonies were screened for kanamycin sensitivity and sequenced to ensure proper construction of the pgp1 clean deletion.
Arylsulfatase activity assays:
For determination of astA activity on XS agar, MH agar was supplemented with 100 g/mL XS (5-bromo-4-chloro-3-indolylsulfate (Sigma-Aldrich)) with or without 0.35 g/mL anhydrotetracycline (ATc) added. Strains to be tested were grown on MH agar from frozen glycerol stocks for 36-48 hours before being struck out on XS agar, followed by an additional 72 hours of incubation.
For spectrophotometric determination of astA activity, strains were grown from frozen glycerol stocks for 36-48 hours before being transferred to MH agar with varying amounts of ATc added, followed by an additional 16-20 hours incubation. The strains were then measured for arylsulfatase activity as described previously. Briefly, cells were washed in PBS and resuspended in arylsulfatase buffer (100 mM tris, 1 mM tyramine hydrochloride, 10 mM nitrophenylsulfate, pH 7.2) and incubated for 1 hour at 37 C. Blank measurements were made using cell suspensions incubated 1 hour at 37 C in arylsulfatase buffer lacking tyramine (100 mM tris, 10 mM nitrophenylsulfate, pH 7.2). After one hour, reactions were stopped by addition of stop solution (0.2 M NaOH) before measurement of absorption at 410 nm. 410 nm absorption readings were converted to enzymatic activity by comparison to a nitrophenol standard curve. Arylsulfatase activity values presented in Fig. 2 and 3 are the average of 3 measurements +/-SEM.
Motility assays:
Comparison of motility between DRH212 (WT) and the PflgR::cat-tetR_PtetA v2 and PflgR::cat-tetR_PtetA v3 strains was made using 0.4% agar MH plates with and without ATc added (0.2 g/mL). Strains were grown from freezer stocks as before and suspended to an O.D.600 of 1.5. 1L of cell suspension was spotted on the motility agar and allowed to incubate for ~12 hours.
Western Blotting:
For detection of FlgR in the PflgR::cat-tetR_PtetA v2 and PflgR::cat-tetR_PtetA v3 backgrounds, cultures were grown from freezer stocks for 48 hours on MH agar followed by inoculation to MH agar with varying concentrations of ATc added (0-0.4 g/mL) and incubated overnight. following overnight incubation, cells were harvested from the plates, washed 1x in PBS and resuspended to an O.D.600 of 0.8. These were then pelleted and resuspended in 200 L 2x SDS-PAGE loading buffer. 5 L of each sample were loaded to each lane of a 4-12% bis-tris gel. Blots were probed for FlgR using FlgR antisera raised in rabbit and developed using HRP-conjugated goat-antirabbit secondary antibody with a ChemidocMP imager (BioRad)
Electron microscopy:
Cells were harvested from MH agar with or without ATc added and suspended to an O.D.600 ~1.0 in PBS. 1 mL of the cell suspension was pelleted and resuspended in 1 mL of fixing buffer (100 mM cacodylic acid, 2% glutaraldehyde, pH 7.4). Fixed samples were applied to glow-discharged, carbon-coated copper grids (Agar scientific) and stained with 2% Uranyl Acetate. Micrographs were recorded on a FEI Tecnai T-12 Spirit 120 KeV electron microscope at 4400x magnification.
Fluorescence microscopy:
For observation of fluorescence in strains harboring the pEJC1 plasmid, cultures were grown overnight on MH agar supplemented with 7.5 g/mL chloramphenicol with or without ATc (0.4 g/mL) added. Cells were harvested from the plates in PBS and stained with FM 4-64 membrane stain, followed by a wash step then resuspended to an O.D.600 of ~1.0 in PBS. Cells were applied to a poly-lysine coated slide and observed on a Leica DMi8 widefield microscope.
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Figure 2: tetRA C.j. v1 and its derivatives regulate target gene expression
The astA promoter was replaced with tetRA C.j. v1 and itsderivatives. (A) Incubation on XS agar with and without ATc added allowed us to determine whether each cassette was able to regulate astA expression and compare the ability of each derivative to repress astA expression. Strains: (1) DRH212, (2) ∆astA, (3) tetRA C.j. v1 , (4) cat-tetR_P tetA v1, (5) tetRA C.j. v2 , (6) cat-tetR_P tetA v2, (7) tetRA C.j. v3 , (8) cat-tetR_P tetA v3. (B) AstA activity from the various cassettes with and without ATc added. (C) cat-tetR_P tetA v2 , cat-tetR_P tetA v3 and cat-RevtetR_P tetA v3 were tested for their ability to regulate motility by contr olling expression of flgR, a response regulator involved in flagellar morphogenesis. Three genes, flgR, astA and pgp1, were used to determine if gene expressi on from the cat-tetR_P tetA promoter. (A) Expression of flgR was tunable using both the cat-tetR_P tetA v2 and cat-tetR_P tetA v3 cassette. In the absence of ATc, FlgR was not detected by western blot. In creasing the amount of ATc led to an increase in FlgR expression for both promoters. (B) AstA activity was nearly undetectable in the P astA ::cat-tetR_P tetA v2 background in the absence of ATc, and was found to peak at a concentratioñ 0.3 μg/mL ATc. Error bars represent the average +/-SEM from three re plicates(C) By placing pgp1 under the control of the cat-tetR_P tetA v2 cassette, the cell body morphology was found to range from a ∆pgp1 straight-body phenotype in the absence of ATc to a WT helical phenotype at 0.3 μg/mL ATc. At lower levels of ATc, a mixture of cell-body morphologies was observe d. Scale bar = 2 µm. 
